Quad Cities Investment Group, LLC Omeros Corp Transaction History

Quad Cities Investment Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.92 - $6.28 $19,584 - $64,056	-10,200 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$5.07 - $7.2 $51,714 - $73,440	10,200 New	10,200 $61,000
Q4 2021 Feb 02, 2022	SELL	$5.67 - $8.54 $74,560 - $112,300	-13,150 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $5,360 - $6,520	-400 Reduced 2.95%	13,150 $181,000
Q1 2021 Apr 29, 2021	BUY	$14.52 - $23.53 $196,746 - $318,831	13,550 New	13,550 $241,000
Q4 2020 Feb 10, 2021	SELL	$10.14 - $15.19 $141,453 - $211,900	-13,950 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$9.57 - $21.32 $8,613 - $19,188	900 Added 6.9%	13,950 $141,000
Q2 2020 Aug 05, 2020	BUY	$12.21 - $16.99 $4,884 - $6,795	400 Added 3.16%	13,050 $192,000
Q3 2019 Oct 25, 2019	SELL	$14.55 - $20.56 $14,550 - $20,560	-1,000 Reduced 7.33%	12,650 $2.07 Million
Q1 2019 Apr 09, 2019	BUY	$11.65 - $17.72 $34,950 - $53,160	3,000 Added 28.17%	13,650 $236,000
Q3 2018 Oct 18, 2018	BUY	$17.73 - $26.69 $31,914 - $48,042	1,800 Added 20.34%	10,650 $260,000
Q2 2018 Aug 07, 2018	BUY	$10.79 - $24.44 $95,491 - $216,294	8,850 New	8,850 $161,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $423M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Quad Cities Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Quad Cities Investment Group, LLC with notifications on news.